Efficacy and Safety of CT-P6 Versus Reference Trastuzumab in HER2-positive Early Breast Cancer: Updated Results of a Randomised Phase 3 Trial
Cancer Chemotherapy and Pharmacology - Germany
doi 10.1007/s00280-019-03920-4
Full Text
Open PDFAbstract
Available in full text
Date
August 19, 2019
Authors
Publisher
Springer Science and Business Media LLC